Nasdaq · CIK 0001527753
PSNL Personalis, Inc.
Insider trading from SEC Form 4. Last filing 20 d ago. Close $16.00 on Oct 9, 2026, +217% from the 52-week low and -13% from the high.
Last 90 days
Net insider value
-$267k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$267k by 4 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
PSNLOct 9, 2026 · close 16.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Personalis, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Richard Chen President and CMO sell | $65k 3,998 shares | -2% | +225% from low-11% from high | |
| 50Moderate | Christopher M Hall Chief Executive Officer sell | $121k 7,459 shares | -3% | +225% from low-11% from high | |
| 36Weak | Stephen Michael Moore SVP and Chief Legal Officer sell | $34k 2,068 shares | -2% | +225% from low-11% from high | |
| 44Moderate | Aaron Tachibana CFO AND COO sell | $48k 2,931 shares | -1% | +225% from low-11% from high | |
| 22Weak | Aaron Tachibana CFO AND COO sell | $1.1M 103,668 shares | -39% | +274% from low0% from high | |
| 43Moderate | Christopher M Hall PRESIDENT AND CEO sell | $266k 29,612 shares | -17% | +200% from low-12% from high | |
| 23Weak | Richard Chen CHIEF MEDICAL OFFICER AND EVP sell | $2,970 452 shares | -0% | +105% from low-18% from high | |
| 30Weak | Aaron Tachibana CFO AND COO sell | $4,211 641 shares | -0% | +105% from low-18% from high | |
| 30Weak | Richard Chen CHIEF MEDICAL OFFICER AND EVP sell | $4,505 910 shares | -1% | +65% from low-25% from high | |
| 30Weak | Stephen Michael Moore SVP and Chief Legal Officer sell | $8,291 1,675 shares | -3% | +65% from low-25% from high | |
| 37Weak | Aaron Tachibana CFO AND COO sell | $6,390 1,291 shares | -1% | +65% from low-25% from high | |
| 15Weak | Richard Chen CHIEF MEDICAL OFFICER AND EVP sell | $3,005 519 shares | -0% | - | |
| 30Weak | Richard Chen CHIEF MEDICAL OFFICER AND EVP sell | $18k 4,834 shares | -4% | - | |
| 30Weak | Stephen Michael Moore SVP and Chief Legal Officer sell | $5,780 1,513 shares | -2% | - | |
| 42Moderate | Aaron Tachibana CFO AND COO sell | $26k 6,865 shares | -4% | - | |
| 30Weak | Richard Chen CHIEF MEDICAL OFFICER AND EVP sell | $3,491 921 shares | -1% | - | |
| 30Weak | Stephen Michael Moore SVP and Chief Legal Officer sell | $6,416 1,693 shares | -2% | - | |
| 37Weak | Aaron Tachibana CFO AND COO sell | $4,954 1,307 shares | -1% | - | |
| 41Moderate | Christopher M Hall PRESIDENT AND CEO sell | $142k 26,443 shares | -13% | - |
Transactions
The last 32 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Christopher M Hall Chief Executive Officer | SOpen-market sale Common Stock | -7,459 | $16.22 | $121k | 228,527 | 20 d ago |
| Sep 18, 2026 | Stephen Michael Moore SVP and Chief Legal Officer | SOpen-market sale Common Stock | -2,068 | $16.22 | $34k | 90,257 | 20 d ago |
| Sep 18, 2026 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock | -2,931 | $16.22 | $48k | 195,902 | 20 d ago |
| Sep 18, 2026 | Richard Chen President and CMO | SOpen-market sale Common Stock | -3,998 | $16.22 | $65k | 169,882 | 20 d ago |
| Mar 15, 2026 | Richard Chen President and CMO | AGrant or award Common Stock | +46,875 | $0.00 | $0 | 173,880 | Mar 17, 2026 |
| Mar 15, 2026 | Richard Chen President and CMO | AGrant or award Stock Option (right to buy)derivative | +281,250 | $0.00 | $0 | 281,250 | Mar 17, 2026 |
| Feb 23, 2026 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Feb 25, 2026 |
| Nov 25, 2025 | Aaron Tachibana CFO AND COO | MOption exercise Common Stock10b5-1 | +103,668 | $9.16 | $950k | 268,126 | Nov 28, 2025 |
| Nov 25, 2025 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock10b5-1 | -103,668 | $10.78 | $1.1M | 164,458 | Nov 28, 2025 |
| Nov 25, 2025 | Aaron Tachibana CFO AND COO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -103,668 | $0.00 | $0 | 108,832 | Nov 28, 2025 |
| Nov 3, 2025 | Christopher M Hall PRESIDENT AND CEO | SOpen-market sale Common Stock | -29,612 | $8.99 | $266k | 148,486 | Nov 5, 2025 |
| Jul 28, 2025 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | SOpen-market sale Common Stock | -452 | $6.57 | $2,970 | 124,505 | Jul 30, 2025 |
| Jul 28, 2025 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock | -641 | $6.57 | $4,211 | 164,458 | Jul 30, 2025 |
| May 16, 2025 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock | -1,291 | $4.95 | $6,390 | 165,099 | May 20, 2025 |
| May 16, 2025 | Lonnie Shoff director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 16, 2025 | Kenneth J Widder director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 16, 2025 | Karin Eastham director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 16, 2025 | Stephen Michael Moore SVP and Chief Legal Officer | SOpen-market sale Common Stock | -1,675 | $4.95 | $8,291 | 64,200 | May 20, 2025 |
| May 16, 2025 | Woodrow A Myers Jr director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 16, 2025 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | SOpen-market sale Common Stock | -910 | $4.95 | $4,505 | 124,957 | May 20, 2025 |
| May 16, 2025 | Olivia Kyusuk Bloom director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 16, 2025 | A Blaine Bowman director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| Mar 15, 2025 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | AGrant or award Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Mar 18, 2025 |
| Mar 15, 2025 | Christopher M Hall PRESIDENT AND CEO | AGrant or award Stock Option (right to buy)derivative | +680,000 | $0.00 | $0 | 680,000 | Mar 18, 2025 |
| Jan 28, 2025 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | SOpen-market sale Common Stock | -519 | $5.79 | $3,005 | 123,367 | Jan 30, 2025 |
| Dec 16, 2024 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | SOpen-market sale Common Stock | -4,834 | $3.82 | $18k | 123,886 | Dec 18, 2024 |
| Dec 16, 2024 | Stephen Michael Moore SVP and Chief Legal Officer | SOpen-market sale Common Stock | -1,513 | $3.82 | $5,780 | 65,875 | Dec 18, 2024 |
| Dec 16, 2024 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock | -6,865 | $3.82 | $26k | 167,098 | Dec 18, 2024 |
| Nov 18, 2024 | Richard Chen CHIEF MEDICAL OFFICER AND EVP | SOpen-market sale Common Stock | -921 | $3.79 | $3,491 | 128,720 | Nov 20, 2024 |
| Nov 18, 2024 | Stephen Michael Moore SVP and Chief Legal Officer | SOpen-market sale Common Stock | -1,693 | $3.79 | $6,416 | 67,388 | Nov 20, 2024 |
| Nov 18, 2024 | Aaron Tachibana CFO AND COO | SOpen-market sale Common Stock | -1,307 | $3.79 | $4,954 | 173,963 | Nov 20, 2024 |
| Nov 1, 2024 | Christopher M Hall PRESIDENT AND CEO | SOpen-market sale Common Stock | -26,443 | $5.38 | $142k | 178,098 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- A Blaine Bowmandirector
- Olivia Kyusuk Bloomdirector
- Richard ChenPresident and CMO
- Karin Easthamdirector
- Christopher M HallPRESIDENT AND CEO
- Woodrow A Myers Jrdirector
- Stephen Michael MooreSVP and Chief Legal Officer
- Lonnie Shoffdirector
- Aaron TachibanaCFO AND COO
- Kenneth J Widderdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.